SONX (Sonendo) Beta: 1.3272 (As of Jun. 24, 2026)


SONX Sonendo Inc SONX
47 GF Score
Price $0.60
View Full Analysis

What is Sonendo Beta?

Sonendo SONX 47 Beta is 1.3272 as of Jun. 24, 2026. GuruFocus rates SONX with a GF Score™ of 47/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Sonendo's Beta is 1.3272.


Sonendo  (OTCPK:SONX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Sonendo Beta Related Terms


Sonendo Beta Historical Data

* Premium members only.

The historical data trend for Sonendo's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonendo Beta Chart

Sonendo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 1.40

Sonendo Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1.51 1.40

SONX vs DHAI, AFIB, ABT: Beta Comparison

For the Medical Devices subindustry, Sonendo's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonendo Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonendo's Beta distribution charts can be found below:

* The bar in red indicates where Sonendo's Beta falls into.


SONX
47GF Score
Sonendo Inc SONX
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonendo Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.3272 mean?
Sonendo (SONX) has a Beta of 1.3272 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sonendo and its competitors.
Is Sonendo's Beta too high?
Sonendo's current Beta is 1.3272. Overall, Sonendo has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Sonendo's Beta compare to DHAI and AFIB?
Sonendo's Beta of 1.3272 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sonendo and its competitors. Sonendo's current Beta is 1.3272. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonendo stock overvalued right now?
Sonendo (SONX) has a current Beta of 1.3272. The current Beta is 1.3272. Sonendo's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Sonendo (SONX), the current Beta is 1.3272 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sonendo Business Description

Address 26061 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the prevalent chronic disease globally. It has developed the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company operates in two business segments, Product segment which derives key revenue, and Software. Product segment includes sales of the Company's GentleWave System console and related accessories and instruments. Software segment includes sales of the company's traditional software licenses for practice management software to enable an integrated digital office for endodontists.
47GF Score

Get the complete analysis for SONX

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price